NF-kappa B: a pivotal role in asthma and a new target for therapy.
Barnes
P J
PJ
Department of Thoracic Medicine, National Heart and Lung Institute, Imperial College, London, UK.
Adcock
I M
IM
D000280:Administration, Inhalation; D000287:Administration, Topical; D001249:Asthma / Q000188:drug therapy / Q000209:etiology* / Q000378:metabolism; D016207:Cytokines / Q000235:genetics / Q000378:metabolism; D005786:Gene Expression Regulation / Q000187:drug effects / Q000235:genetics; D005938:Glucocorticoids / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D016328:NF-kappa B / Q000037:antagonists & inhibitors / Q000235:genetics* / Q000378:metabolism; D016877:Oxidants / Q000378:metabolism
D016207:Cytokines; D005938:Glucocorticoids; D016328:NF-kappa B; D016877:Oxidants